lenalidomide aurobindo
eugia pharma (malta) limited - lenalidomide - lenalidomide
lenalidomide biocon
biocon pharma malta i limited - lenalidomide - lenalidomide
lenalidomide grindeks
as grindeks - lenalidomide - lenalidomide
gazyvaro 1000 mg/40 ml concentrato per soluzione per infusione
roche pharma (schweiz) ag - obinutuzumabum - concentrato per soluzione per infusione - obinutuzumabum 1000 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 40 ml. - la leucemia linfatica cronica, linfoma follikuläres - biotechnologika
venclyxto 10 mg compresse rivestite con film
abbvie ag - venetoclaxum - compresse rivestite con film - venetoclaxum 10 mg, copovidonum k 28, polysorbatum 80, silica colloidalis anhydrica, calcii phosphas, natrii stearylis fumaras corresp. natrium 0.03 mg, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), pro compresso obducto. - chronisch lymphatische leukämie (cll), akute myeloische leukämie (aml) - synthetika
venclyxto 50 mg compresse rivestite con film
abbvie ag - venetoclaxum - compresse rivestite con film - venetoclaxum 50 mg, copovidonum k 28, polysorbatum 80, silica colloidalis anhydrica, calcii phosphas, natrii stearylis fumaras corresp. natrium 0.15 mg, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - chronisch lymphatische leukämie (cll), akute myeloische leukämie (aml) - synthetika
venclyxto 100 mg compresse rivestite con film
abbvie ag - venetoclaxum - compresse rivestite con film - venetoclaxum 100 mg, copovidonum k 28, polysorbatum 80, silica colloidalis anhydrica, calcii phosphas, natrii stearylis fumaras corresp. natrium 0.31 mg, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), pro compresso obducto. - chronisch lymphatische leukämie (cll), akute myeloische leukämie (aml) - synthetika
lenalidomide mylan
mylan ireland limited - lenalidomide - mieloma multiplo - immunosoppressori - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).
levact
pharmaand gmbh - bendamustina - bendamustina
bendamustina accord
accord healthcare, s.l.u. - bendamustina - bendamustina